Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells
Authors:
Open Access
- 1 January 1991
- journal article
- Published by American Society of Hematology in Blood
- Vol. 77 (1) , 149-158
Abstract
The steady-state expression of three members of the myb family of genes, c-myb, B-myb, and A-myb, was studied in four purified normal human hematopoietic cell types, ie, T and B lymphocytes, monocytes, and granulocytes. The c-myb proto-oncogene is low to undetectable in resting T and B lymphocytes and shows a biphasic induction in both cell types after mitogenic stimulation, with a first peak at 3 hours and a second and stronger induction at 44 to 72 hours. Study of the B-myb gene showed that this gene is low to undetectable in resting T or B cells and is strongly induced after mitogenic stimulation with a peak between 44 and 72 hours in both cell types. Finally, the A-myb gene shows a pattern of expression in lymphocytes different from that of c- myb and B-myb. It is expressed in resting T lymphocytes and its levels gradually decrease after mitogenic stimulation to become undetectable at 48 hours. It is also expressed in a subpopulation of large B lymphocytes but not in in vitro activated B cells. Neither of the three members of the myb family of genes was expressed in monocytes and granulocytes, even after functional activation of these cells. Taken together, these data bring further evidence for the role of c-myb in cellular proliferation and on the basis of the kinetics of its induction relative to thymidine uptake, we hypothesize that it may have a role during G1 progression in addition to that already documented for entry into S phase. Furthermore, our studies indicate that another member of the myb family of genes, B-myb, may also be involved in cellular proliferation, because its expression correlates with the induction of mitogenesis.Keywords
This publication has 12 references indexed in Scilit:
- Delineation of three functional domains of the transcriptional activator encoded by the c-myb protooncogene.Proceedings of the National Academy of Sciences, 1989
- An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines.Proceedings of the National Academy of Sciences, 1989
- Serum-Inducible Genes1989
- Expression of the human B-cell surface protein CD20: alteration by phorbol 12-myristate 13-acetate.Proceedings of the National Academy of Sciences, 1987
- Expression of c-fos protooncogene in normal human peripheral blood granulocytes.Journal of Experimental Medicine, 1987
- Cellular levels of mRNA from c‐myc, c‐myb and c‐fes onc‐genes in normal myeloid anderythroid precursors of human bone marrow: an in situ hybridization studyBritish Journal of Haematology, 1986
- Expression of the c-myb proto-oncogene during cellular proliferationNature, 1986
- Expression of a proto-oncogene (proto-myb) in hemopoietic tissues of mice.Molecular and Cellular Biology, 1984
- Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.The Journal of Immunology, 1984
- Avian leukemia viruses interaction with their target cells in vivo and in vitroBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1978